bioMérieux: interim earnings up by a third
(CercleFinance.com) - bioMérieux has published H1 2018 net income that is up 33% at 134 million euros, with a 7% increase in contributive operating income to 185 million euros, meaning a margin of 15.
8% compared to 15.2% over H1 2017.
At 30 June 2018, sales of the in-vitro diagnostic specialist reached 1.169 billion euro, up 3.1% as reported and up 10.4% like-for-like.
Given this performance, bioMérieux now targets organic sales growth of around 9.5%, with an active operating result of 340 million to 350 million euros at current exchange rates.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
8% compared to 15.2% over H1 2017.
At 30 June 2018, sales of the in-vitro diagnostic specialist reached 1.169 billion euro, up 3.1% as reported and up 10.4% like-for-like.
Given this performance, bioMérieux now targets organic sales growth of around 9.5%, with an active operating result of 340 million to 350 million euros at current exchange rates.
Copyright (c) 2018 CercleFinance.com. All rights reserved.